Growth Metrics

Ceribell (CBLL) Debt Ratio (2024 - 2026)

Ceribell posted quarterly Debt Ratio of 0.11 for Q1 2026, up 21.7% year-on-year from 0.09 in Q1 2025, and up 10.54% on a QoQ basis from 0.1 in Q4 2025.

Ceribell (CBLL) has 3 years of Debt Ratio data on file, last reported at 0.11 in Q1 2026.

  • For the quarter ending Q1 2026, Debt Ratio rose 21.7% year-over-year to 0.11; the trailing twelve-month figure through Mar 2026 stood at 0.11 (up 21.7% YoY), and the FY2025 full-year result was 0.1, up 16.61% from the prior year.
  • Debt Ratio for Q1 2026 stood at 0.11, up from 0.1 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.41 in Q3 2024 and bottomed at 0.09 in Q4 2024.
  • The 3-year median for Debt Ratio is 0.1 (2025), against an average of 0.14.
  • The widest annual swing landed in 2025, when Debt Ratio sank 76.11%; it then rose 21.7% in 2026.
  • A 3-year view of Debt Ratio shows it stood at 0.09 in 2024, then grew by 16.61% to 0.1 in 2025, then increased by 10.54% to 0.11 in 2026.
  • The last three Debt Ratio figures came in at 0.11 (Q1 2026), 0.1 (Q4 2025), and 0.1 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.31
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.32
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.31
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.25
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.04
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.25
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.27
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.18
10 Ceribell 666.26 Mn 525.07 Mn 23.12 Mn 0.11

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.11
Dec 31, 2025 0.10
Sep 30, 2025 0.10
Jun 30, 2025 0.09
Mar 31, 2025 0.09
Dec 31, 2024 0.09
Sep 30, 2024 0.41